Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Open in API
Filings indexed 2,730 across all filing types
Latest filing 2025-07-18 Regulatory Filings
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
114年7月變更登記
Regulatory Filings Classification · 95% confidence The document is a brief disclosure from a listed company (美時) providing details about its capital stock, including authorized capital, paid-in capital, and changes in capital structure. It includes specific numeric data about shares and capital amounts but does not contain financial statements, management discussion, or detailed financial performance data. The document length is only 847 characters, indicating it is a short announcement rather than a full report. There is no indication of an earnings release, annual or interim report, or other detailed filings. The content focuses on capital stock information, but it is not a new share issuance announcement or share repurchase. Given the nature and brevity, this fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2025-07-18 Chinese
114年6月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a company named 美時, providing data on fund lending balances and endorsement guarantees for the current and previous month, including limits and cumulative amounts. The content is brief (619 characters) and consists mainly of tabular financial data related to internal and subsidiary financial activities. There is no indication of a full financial report, audit, or management discussion. It is a regulatory disclosure of financial status related to fund lending and guarantees, typical of a regulatory filing. Given the short length and nature of the data, it does not qualify as a full Annual Report, Interim Report, or Earnings Release. It fits best under Regulatory Filings (RNS) as a general compliance disclosure.
2025-07-10 Chinese
114年6月營業收入
Fund Information / Factsheet Classification · 85% confidence The document is a revenue summary report provided by a listed company, showing monthly and cumulative net operating revenue figures with year-over-year comparisons. It includes notes on accounting standards (IFRS) and reporting practices but does not contain comprehensive financial statements or detailed analysis. The document length is short (777 characters) and appears to be a brief financial data summary rather than a full report. It is not an announcement of a report publication, nor is it a certification or legal filing. Given the nature of the content as a brief summary of key financial figures, it best fits the category of Fund Information / Factsheet (FS).
2025-07-10 Chinese
114年06月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings and changes in share ownership by insiders, including directors, general managers, and other executives. It includes data on shares held, increases, decreases, and trust shares. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There are no indications of financial statements, earnings data, or meeting materials. The document is not a report publication announcement or a certification. Given the detailed insider shareholding data, this fits the definition of Director's Dealing (DIRS).
2025-07-10 Chinese
114年06月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabular disclosure of shareholdings by company insiders, including directors, supervisors, and senior management, showing their current and initial shareholdings, pledged shares, and related information. It does not contain financial statements, earnings data, or management discussion. It is a report on insider shareholdings and related disclosures. This type of document corresponds to Director's Dealing filings, which report personal share transactions or holdings by company directors and executives. The document length is under 5,000 characters and contains detailed insider shareholding data, not a mere announcement or certification. Therefore, the appropriate classification is Director's Dealing (DIRS).
2025-07-10 Chinese
114年年報及股東會資料 — 2025_1795_20250626F05.pdf
AGM Information Classification · 100% confidence The document is a detailed record of a company's Annual General Meeting (AGM) held in 2024, including agenda items such as approval of the previous year's business report and financial statements, audit committee report, employee and director remuneration, dividend distribution, share buyback report, amendments to company bylaws, capital increase discussions, election of a director, and other shareholder discussions. It contains voting results and detailed discussions typical of AGM minutes. The document also includes the company's 2024 business report and financial statements as attachments, which are referenced but not the primary content of this document. The length is substantial (15,000 characters), and the content is the meeting minutes and resolutions rather than just an announcement or a proxy statement. Therefore, the document fits the category of AGM Information (AGM-R).
2025-07-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.